YSB Inc. (9885.HK)
- Previous Close
7.380 - Open
7.400 - Bid 7.470 x --
- Ask 7.500 x --
- Day's Range
7.350 - 7.600 - 52 Week Range
5.180 - 9.080 - Volume
1,759,600 - Avg. Volume
4,879,817 - Market Cap (intraday)
5.106B - Beta (5Y Monthly) --
- PE Ratio (TTM)
150.00 - EPS (TTM)
0.050 - Earnings Date --
- Forward Dividend & Yield 0.08 (1.10%)
- Ex-Dividend Date May 23, 2025
- 1y Target Est
--
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products. Further, it provides medical testing services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.
www.ysbang.cn6,763
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 9885.HK
View MorePerformance Overview: 9885.HK
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 9885.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 9885.HK
View MoreValuation Measures
Market Cap
5.02B
Enterprise Value
3.14B
Trailing P/E
137.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.25
Price/Book (mrq)
2.02
Enterprise Value/Revenue
0.16
Enterprise Value/EBITDA
18.94
Financial Highlights
Profitability and Income Statement
Profit Margin
0.17%
Return on Assets (ttm)
-1.02%
Return on Equity (ttm)
0.73%
Revenue (ttm)
17.9B
Net Income Avi to Common (ttm)
30.01M
Diluted EPS (ttm)
0.050
Balance Sheet and Cash Flow
Total Cash (mrq)
1.99B
Total Debt/Equity (mrq)
10.29%
Levered Free Cash Flow (ttm)
681.38M